MAPT and early-onset autosomal dominant Alzheimer disease: This prognostic study examines the prognostic accuracy of baseline [18F]flortaucipir and [18F]RO948 (tau) positron emission tomography (PET) in individuals across the Alzheimer disease clinical spectrum and performs a head-to-head comparison with established magnetic resonance imaging and amyloid PET markers.